Next Post

Antibe Therapeutics Announces Discontinuation of Latin American Letter of Intent – Business Wire (press release)

Antibe Therapeutics Announces Discontinuation of Latin American Letter of IntentBusiness Wire (press release)TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV: ATE) announces that discussions with the potential Latin American partner with which it executed an LOI in 2012 have been discontinued due to a recent change … and more »